Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

REIMAGINE 1, 2 and 3 – trial designs, key results and clinical perspectives 

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Diabetes
Congress oral presentation
Amylin
CagriSema
PHASE 3 (RCT)